{"id":"W1978182027","doi":"10.1038/npp.2014.214","title":"Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain","year":2014,"lang":"en","type":"article","venue":"Neuropsychopharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Brookhaven National Laboratory; Biological and Environmental Research; National Institute on Drug Abuse; National Institutes of Health; Valeant Pharmaceuticals International; American Academy of Neurology; U.S. Department of Energy","keywords":"Selegiline; Monoamine oxidase B; Pharmacology; Clorgyline; Antidepressant; CYP2D6; Amphetamine; Monoamine oxidase; Dopamine; Chemistry; Internal medicine; Endocrinology; Medicine; Metabolism; Parkinson's disease; Enzyme; Biochemistry; Cytochrome P450; Hippocampus","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005609701,0.0003230055,0.0004817284,0.0001998183,0.000294671,0.00002263351,0.0004290281,0.0001492808,0.0001455601],"category_scores_gemma":[0.0003673887,0.0002032963,0.0001956724,0.001043397,0.0001259912,0.0001690214,0.0001101871,0.000564953,0.000028508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007439114,"about_ca_system_score_gemma":0.0001175786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006879912,"about_ca_topic_score_gemma":0.0002548264,"domain_scores_codex":[0.9971744,0.0008267701,0.0004629972,0.0005667549,0.000494672,0.0004743403],"domain_scores_gemma":[0.9980128,0.0007320798,0.0003456826,0.0005797515,0.0001909337,0.0001386995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002466648,0.005412715,0.2106664,0.0004029405,0.0008663373,0.0001962246,0.004983737,0.0004216285,0.7119129,0.01103734,0.04638761,0.005245477],"study_design_scores_gemma":[0.007297843,0.0005443317,0.9388416,0.0001450737,0.0006454726,0.00008934302,0.00008320168,0.0007327081,0.01895663,0.001427406,0.03099206,0.0002443059],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845958,0.0003526075,0.00009626853,0.01073515,0.0007869061,0.001413294,0.00002713237,0.00005161611,0.001941232],"genre_scores_gemma":[0.9925703,0.0001038425,0.0001083593,0.006380714,0.0003187051,0.0002420785,0.00001171886,0.00004506519,0.0002192388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7281752,"threshold_uncertainty_score":0.8290183,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03321536608248089,"score_gpt":0.3269877369995647,"score_spread":0.2937723709170838,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}